Nice find. This seems to be investigator-led or academic initiative, no sponsor is listed and it’s not registered on clinicaltrials.gov, suggesting it’s very early stage (Phase 1 or pilot) or not intended for commercial development.
Bringing a new product to market would take years if successful. If anything, this validates the need for a safe and effective palmar solution, which Sofdra could potentially step into.
Nice find. This seems to be investigator-led or academic...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.8¢ |
Change
0.013(4.39%) |
Mkt cap ! $583.3M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 30.0¢ | 28.5¢ | $1.134M | 3.894M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 163731 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 1043236 | 22 |
View Market Depth
| Last trade - 12.46pm 20/06/2025 (20 minute delay) ? |
| BOT (ASX) Chart |